Buspirone
- Generic Name
- Buspirone
- Brand Names
- Buspar
- Drug Type
- Small Molecule
- Chemical Formula
- C21H31N5O2
- CAS Number
- 36505-84-7
- Unique Ingredient Identifier
- TK65WKS8HL
- Background
Buspirone is a novel anxiolytic agent with a unique structure and a pharmacological profile. Belonging to the azaspirodecanedione drug class, buspirone is a serotonin 5-HT receptor agonist that is not chemically or pharmacologically related to benzodiazepines, barbiturates, and other sedative/anxiolytic drugs. Unlike many drugs used to treat anxiety, buspiro...
- Indication
Indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety.
- Associated Conditions
- Anxiety Disorders, Depression
- Associated Therapies
- -
Dexmed/Buspirone Synergism on Shivering
- Conditions
- Interventions
- First Posted Date
- 2006-06-07
- Last Posted Date
- 2016-06-29
- Lead Sponsor
- The Cleveland Clinic
- Target Recruit Count
- 8
- Registration Number
- NCT00334360
- Locations
- 🇺🇸
Outcomes Research Institute, University of Louisville, Louisville, Kentucky, United States
Effects of Buspirone in Opiate Withdrawal
- Conditions
- First Posted Date
- 2006-05-16
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00326235
- Locations
- 🇺🇸
VA New York Harbor Healthcare System - Brooklyn Campus, Brooklyn, New York, United States
Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar
- Conditions
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2008-07-15
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 241
- Registration Number
- NCT00174226
- Locations
- 🇺🇸
Pfizer Investigational Site, Woodstock, Vermont, United States
Early Pharmacotherapy Aimed at Neuroplasticity in Autism : Safety and Efficacy
- Conditions
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2011-07-20
- Lead Sponsor
- Chugani, Diane C.
- Target Recruit Count
- 20
- Registration Number
- NCT00166621
- Locations
- 🇺🇸
PET Center/Children's Hospital of Michigan, Detroit, Michigan, United States
Effectiveness of Buspirone and Motivational Enhancement Therapy for the Treatment of Marijuana Dependence - 1
- Conditions
- First Posted Date
- 2005-09-08
- Last Posted Date
- 2015-10-09
- Lead Sponsor
- Medical University of South Carolina
- Target Recruit Count
- 81
- Registration Number
- NCT00149617
- Locations
- 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States
Sequenced Treatment Alternatives to Relieve Depression (STAR*D)
- Conditions
- First Posted Date
- 2001-07-23
- Last Posted Date
- 2009-09-25
- Lead Sponsor
- National Institute of Mental Health (NIMH)
- Target Recruit Count
- 4000
- Registration Number
- NCT00021528
- Locations
- 🇺🇸
Harbor UCLA Family Health Care Center, Harbor City, California, United States
🇺🇸UCLA General Outpatient Psychiatry Clinic, Los Angeles, California, United States
🇺🇸UCLA Internal Medicine Clinic, Los Angeles, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.